Published in Transplant Proc on September 26, 2005
Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report. J Med Case Rep (2008) 0.92
The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report. J Med Case Rep (2016) 0.76
A Case of Skin, and Secondarily Generalized, Reaction to Insulin Injection. Clin Diabetes (2014) 0.75
Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report. J Pediatr Pharmacol Ther (2016) 0.75
Identifying relevant studies for systematic reviews. BMJ (1994) 12.21
The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell (1995) 5.50
Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature (1996) 4.55
Handsearching versus electronic searching to identify reports of randomized trials. Cochrane Database Syst Rev (2007) 2.91
A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat Cell Biol (1999) 2.84
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med (1999) 2.33
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol (2008) 2.28
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation (1999) 2.27
Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev (2002) 2.15
An investigation of the adequacy of MEDLINE searches for randomized controlled trials (RCTs) of the effects of mental health care. Psychol Med (1994) 2.08
Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis (1999) 2.05
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90
Asymmetric division in mouse oocytes: with or without Mos. Curr Biol (2000) 1.84
Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology (2006) 1.77
Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev (2004) 1.74
IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. Clin Chem (1997) 1.67
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus (1995) 1.63
Cushing syndrome and medroxyprogesterone acetate. Lancet (1990) 1.60
Safe preservation of human renal cadaver transplants by Euro-Collins solution up to 50 hours. Transplant Proc (1981) 1.50
Hyperglycaemic effect of nifedipine. Br Med J (Clin Res Ed) (1981) 1.50
The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther (1998) 1.42
[Screening strategy and diagnostic criteria for gestational diabetes. Proposals of the GGOLFB]. Rev Med Brux (2012) 1.40
[Is there a link between secondary hemochromatosis and genetics? Apropos of 2 cases]. Acta Clin Belg (1999) 1.39
Bone mass evolution after renal transplantation. Kidney Int (2001) 1.38
Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int (1994) 1.38
Technetium-99m L,L-ethylenedicysteine clearance and correlation with iodine-125 orthoiodohippurate for the determination of effective renal plasma flow. Eur J Nucl Med (1996) 1.37
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer (2005) 1.36
Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc (1987) 1.35
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation (2000) 1.33
A comparison of handsearching versus MEDLINE searching to identify reports of randomized controlled trials. Stat Med (2002) 1.31
Mos activates MAP kinase in mouse oocytes through two opposite pathways. EMBO J (2000) 1.16
An outbreak of Ochrobactrum anthropi bacteraemia in five organ transplant patients. J Hosp Infect (1994) 1.16
Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil. Ther Drug Monit (2003) 1.10
Genomic characterization of the mouse inhibitor of apoptosis protein 1 and 2 genes. Genomics (1997) 1.08
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Transient sterile chemical peritonitis in a CAPD patient using icodextrin. Perit Dial Int (2002) 1.08
Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis. Clin Nephrol (1997) 1.07
Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil. Clin Chem (2001) 1.06
Evaluation of Toll-like receptor and adaptor molecule polymorphisms for susceptibility to tuberculosis in a Colombian population. Int J Immunogenet (2012) 1.05
[Palpebral asymmetry and Graves' ophthalmopathy]. Acta Neurol Belg (1988) 1.05
Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A. Acta Clin Belg (1995) 1.04
Gastric acid and pancreatic polypeptide responses to sham feeding are impaired in diabetic subjects with autonomic neuropathy. Diabetes (1985) 1.04
The interaction between clarithromycin and cyclosporine in kidney transplant recipients. Transplantation (1994) 1.03
Self-reported and measured weights and heights of participants in community-based weight loss programs. J Am Diet Assoc (1992) 1.02
Outcome of patients with tuberous sclerosis after renal transplantation. Transplantation (1990) 1.02
Prevalence of thyroid cancer in Graves' disease: a retrospective study of a cohort of 103 patients treated surgically. Eur J Intern Med (2003) 1.02
Skin granulomas due to Mycobacterium gordonae. Int J Dermatol (1987) 1.02
Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol (2000) 1.01
Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (1996) 1.01
Hepatic abscess likely related to Leptotrichia buccalis in an immunocompetent patient. Liver (1996) 1.01
Combined immunosuppressive therapy with cyclosporin A and azathioprine. A synergistic effect in three of four experimental models. Transplantation (1982) 1.01
Hepatic angiomyo(myelo)lipoma: difficulties in radiological diagnosis and interest of fine needle aspiration biopsy. Liver (1996) 0.99
Video-assisted neck exploration for primary and secondary hyperparathyroidism: initial experience. Surg Endosc (2001) 0.98
Multiple spontaneous ruptures of tendons in renal transplant recipient. Br Med J (Clin Res Ed) (1984) 0.96
Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation (2002) 0.96
Haematological changes and infectious complications in anorexia nervosa: a case-control study. Q J Med (1993) 0.94
Course of Henoch-Schönlein nephritis after renal transplantation. Report on ten patients and review of the literature. Transplantation (1994) 0.94
Hemolytic uremic syndrome in three adult siblings: a familial study and evolution. Clin Nephrol (1987) 0.94
Increase of physical activity level after successful renal transplantation: a 5 year follow-up study. Nephrol Dial Transplant (2001) 0.94
Urothelial malignancy in nephropathy due to Chinese herbs. Lancet (1994) 0.94
Multiple bilateral fibroadenomas of the breasts requiring mastectomy in a renal transplant patient. Clin Nephrol (2004) 0.94
Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. Clin Chem (2001) 0.94
Assignment of human inhibitor of apoptosis protein (IAP) genes xiap, hiap-1, and hiap-2 to chromosomes Xq25 and 11q22-q23 by fluorescence in situ hybridization. Genomics (1996) 0.94
Molecular dissociative ionization and wave-packet dynamics studied using two-color XUV and IR pump-probe spectroscopy. Phys Rev Lett (2009) 0.93
Urine protein 1: a sex-dependent marker of tubular or glomerular dysfunction. Clin Chem (1989) 0.92
Serum lipoprotein(a) in patients with diabetes mellitus. Diabetes Care (1993) 0.92
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia. Leukemia (2008) 0.92
[Hantavirus nephropathy in Belgium: description of 2 new cases originating in southern provinces]. Acta Clin Belg (1987) 0.92
Human ABO-incompatible living donor renal homografts. Neth J Med (1985) 0.92
Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischaemia: mid-term results. Eur J Vasc Endovasc Surg (2000) 0.91
Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int (1995) 0.91
Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J Am Soc Nephrol (1999) 0.91
Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection. Clin Nephrol (2006) 0.90
MAST3: a novel IBD risk factor that modulates TLR4 signaling. Genes Immun (2008) 0.90
Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors. Clin Nephrol (1998) 0.90
Bone density and markers of bone remodeling in type 1 male diabetic patients. Diabetes Metab (2006) 0.89
STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma. Oncogene (2012) 0.89
Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique. Leukemia (2006) 0.89
Nickel contact sensitivity in women and HLA antigens. Arch Dermatol Res (1980) 0.89
Acute colonic complications after kidney transplantation. Acta Chir Belg (1995) 0.89
Exenatide improves weight loss insulin sensitivity and β-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy. Ann Endocrinol (Paris) (2011) 0.89
Contributions of the video-assisted approach to thyroid and parathyroid surgery. Acta Chir Belg (2002) 0.89
Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas. Eur J Endocrinol (1998) 0.88
ANCA-positive rapidly progressive glomerulonephritis: there may be more to the diagnosis than you think! Nephrol Dial Transplant (1997) 0.88
Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol (1998) 0.87
Difficulty with MEDLINE searches for randomised controlled trials. Lancet (1992) 0.87
Identifying systematic reviews: key resources. ACP J Club (2000) 0.87
CRP measurement: does the assay matter in hemodialysis patients? Clin Nephrol (2008) 0.87
FISH detection of chromosome polymorphism and deletions in the spinal muscular atrophy (SMA) region of 5q13. Cytogenet Cell Genet (1996) 0.87
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients. Leukemia (2010) 0.86
Prospective evaluation of thoracic-duct drainage in the treatment of respiratory failure complicating severe acute pancreatitis. Intensive Care Med (1989) 0.86
Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites. Diabetes Metab (2006) 0.86
MRI of cervical cord lesions and their resolution in Toxocara canis myelopathy. Neuroradiology (1996) 0.86
Identifying reports of controlled trials in the BMJ and the Lancet. BMJ (1996) 0.86
Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome. Acta Clin Belg (2014) 0.86